Open access
Virology
Research Article
21 June 2024

Gemykibivirus detection in acute encephalitis patients from Nepal

Special Series: Diversity, Equity, and Inclusivity 

ABSTRACT

Acute encephalitis syndrome (AES) causes significant morbidity and mortality worldwide. In Nepal, Japanese encephalitis virus (JEV) accounts for ~5-20% of AES cases, but ~75% of AES cases are of unknown etiology. We identified a gemykibivirus in CSF collected in 2020 from an 8-year-old male patient with AES using metagenomic next-generation sequencing. Gemykibiviruses are single stranded, circular DNA viruses in the family Genomoviridae. The complete genome of 2,211 nucleotides was sequenced, which shared 98.69% nucleotide identity to its closest relative, Human associated gemykibivirus 2 isolate SAfia-449D. Two real-time PCR assays were designed, and screening of 337 cerebrospinal fluid (CSF) and 164 serum samples from AES patients in Nepal collected in 2020 and 2022 yielded 11 CSF and 1 serum sample that were positive in both PCR assays. Complete genomes of seven of the positives were sequenced. These results identify a potential candidate etiologic agent of encephalitis in Nepal.

IMPORTANCE

Viral encephalitis is a devastating disease, but unfortunately, worldwide, the causative virus in many cases is unknown. Therefore, it is important to identify viruses that could be responsible for cases of human encephalitis. Here, using metagenomic sequencing of CSF, we identified a gemykibivirus in a male child from Nepal with acute encephalitis syndrome (AES). We subsequently detected gemykibivirus DNA in CSF or serum of 12 more encephalitis patients by real-time PCR. The virus genomes we identified are highly similar to gemykibiviruses previously detected in CSF of three encephalitis patients from Sri Lanka. These results raise the possibility that gemykibivirus could be an underrecognized human pathogen.

INTRODUCTION

Encephalitis is a neurological disorder associated with a high mortality rate on a global scale (1). It is the inflammation of the brain parenchyma with clinical features of fever, altered mental state, and/or new onset of seizures. At present, low sociodemographic index regions in Asia and Africa carry the highest burden of encephalitis (2). In the year 2021, a total of 512 cases of acute encephalitis syndrome (AES) were reported in Nepal (3). More than 100 different infectious agents that cause encephalitis are known including bacteria, viruses, fungi, and parasites (4, 5). The major known etiologic agents of encephalitis as reported in Nepal and internationally are Japanese encephalitis virus (JEV), enteroviruses, herpes simplex, and varicella zoster viruses (6, 7). In Nepal, there has been a national surveillance program for JEV since 2004 wherein CSF and serum samples of suspected viral cases of encephalitis are collected from sentinel sites throughout Nepal with technical support from WHO and analyzed at the National Public Health Laboratory (NPHL) by serology for anti-JEV IgM. In numerous studies in Nepal assessing cases since 2000, ~ 70-95% of the AES cases per year have no diagnosis (3, 811). A significant fraction of encephalitis in other countries similarly lacks diagnosis, despite extensive testing (5, 12, 13). In recent years, the application of metagenomic analysis to patients with encephalitis has begun to identify a range of emerging viruses linked to encephalitis (1419).
The Genomoviridae family of viruses has single stranded DNA genomes of ~2.1–2.2 kb (20) that encode a capsid protein (CP) and a replication associated protein (REP). They have been identified from a wide range of hosts including plants, insects, animals, and humans (2022). There are ten genera in the Genomoviridae family (20). Viruses in the genus Gemykibivirus have been identified in multiple human cases and in multiple specimen types including blood of febrile Tanzanian children (23), the respiratory tract of an elderly woman with respiratory distress in China (24), feces from diarrhea patients in Brazil (25), blood of healthy blood donors of Brazil (21), blood of HIV-positive Cameroonian males (26), and in cervical swab of HIV/HPV-infected pregnant females (27). Specific to encephalitis, there are reports of gemykibiviruses in CSF from an encephalitic child from China (15) and CSF from three patients with encephalitis from Sri Lanka (25). Furthermore, analysis of Nepalese sewage yielded the complete genome of a gemykibivirus (25). Here, we used metagenomic next generation sequencing (NGS) to identify the presence of a gemykibivirus in CSF from a patient with encephalitis in Nepal. Further PCR screening identified 12 additional positive cases.

RESULTS

Detection of a gemykibivirus by metagenomic NGS

NGS of nucleic acids extracted from the CSF of an 8-year-old boy yielded reads that could be assembled into two contigs that shared 97 and 99% nucleotide similarity with Human associated gemykibivirus 2 SAfia-449D (accession# MN765187.1). Using PCR, gaps between the two contigs were spanned to generate a complete circular genome of 2211 nt. To formally assess the taxonomic relationship of this virus to viruses in the family Genomoviridae, we generated a maximum likelihood phylogenetic tree of the REP protein with the type species of each genus, in accordance with the ICTV guidelines (20, 22) (Fig. 1A). The virus was most similar to the prototype virus from the genus Gemykibivirus. To further assess its relationship within the genus Gemykibivirus, we generated a maximum likelihood tree using the whole genome sequence (Fig. 1B), which demonstrated that it is most closely related to Human associated gemykibivirus 2 SAfia-449D, a virus detected in the blood of Tanzanian children (23), with 98.69% nucleotide identity. Based on these criteria, the virus genome from the index case was designated Human gemykibivirus 2 Nepal/N0000051/2020. Human gemykibivirus 2 Nepal/N0000051/2020 was also closely related to Gemycircularvirus-SL1 (accession# KP133075), a previously reported gemykibivirus detected in CSF from an encephalitis patient in Sri Lanka (25) sharing 97.96% nucleotide identity (33 single nucleotide polymorphisms [SNPs] across the genome and a 12-bp insertion located in a region of tandem repeat hexamers), and it shared 98.64% identity to another gemykibivirus, Gemycircularvirus NP (accession# KP133080), detected in sewage from Nepal (25).
Fig 1
Fig 1 Phylogenetic trees of (A) amino acid sequences of the index case REP protein and representatives of each genus in the family Genomoviridae; (B) whole genome nucleotide sequences of the positive samples from Nepal compared with other genomes within the genus Gemykibivirus.
Gene predictions identified three open reading frames (ORFs), characteristic of Gemykibiviruses (Fig. 2). The CP ORF is 969 bp, the REP ORF, generated by splicing is 1114 bp, and the unknown ORF3, which overlaps with the REP ORF, is 702 bp. A large intergenic region (LIR) of 127 bp is present, and the putative viral origin of replication nona-nucleotide motif 5′-TAAAATTTA-3′ described in Gemycircularvirus NP (accession# KP133080) is conserved. A predicted stem loop in the LIR is observed from nucleotides 23 to 57. The stem loop structure is present in genomoviruses and geminiviruses where it is necessary for rolling circle replication (28, 29).
Fig 2
Fig 2 Schematic of the genome of Human gemykibivirus 2 Nepal/N0000051/2020.

Identification of additional positive specimens from encephalitis patients

To define the prevalence of this virus, two Taqman real-time PCR assays were designed and validated, one targeting the REP gene and one targeting the CP gene. A total of 337 CSF samples and 164 serum samples were tested using both assays. Sample with Ct. values <33 for both assays were considered positive. There were three gemykibivirus positive CSF specimens from 2020 and nine positive specimens (eight CSF and one serum) from 2022 (Table 1). The prevalence rate in CSF was 3.3% (11/337) and in serum was 0.6% (1/164). Positive patients ranged from 4 months to 72 years of age. Including the index case, there were seven male and six female patients. Geographically, most positive patients were from districts in south-central Nepal (Fig. 3). Unfortunately, no additional clinical details are available for the patients in this study besides meeting the acute case definition of encephalitis.
TABLE 1
TABLE 1 Patient demographics and quantitative real-time PCR (qPCR) Ct. values of gemykibivirus positive casesd
Sample IDSpecimenAgeGenderCt.
Gemy_1a
Ct.
Gemy_2b
Specimen collection dateDistrictcProvince
N0000218CSF14 yrsM32.4230.682020 FebKaskiGandaki
N0000256CSF9 mosF29.4129.342020 JulyMyagdiGandaki
N0000300CSF8 yrsF32.9531.462020 SepPalpaLumbini
N0000358Serum6 mosM29.2729.942022 FebSarlahiMadhesh
N0000359CSF5 yrsF27.427.082022 FebKapilvastuLumbini
N0000395CSF4 mosM30.7430.732022 AprilKaskiGandaki
N0000434CSF57 yrsM29.0230.062022 JuneLalitpurBagmati
N0000468CSF35 yrsF30.8431.472022 JulyChitwanBagmati
N0000490CSFUnknownM29.8632.082022 JulySyangjaGandaki
N0000545CSF72 yrsF26.8425.352022 AugKathmanduBagmati
N0000546CSF21 yrsM24.6523.532022 AugKathmanduBagmati
N0000722CSF25 yrsF28.7429.722022 NovChitwanBagmati
a
Gemy_1: qPCR targeting capsid protein gene.
b
Gemy_2: qPCR targeting replication associated protein (REP) gene.
c
Districts involved are highlighted in Fig. 3 as shade.
d
Ct., cycle threshold; yrs, years; mos, months.
Fig 3
Fig 3 Map of Nepal and locations of the gemykibivirus positive cases (shaded). The map was adapted from https://github.com/itsbohara/nepal-gis.git under Apache License 2.0.

Whole genome sequencing and phylogenetic analysis of additional positive cases

From the 10 positive specimens with the highest Gemykibivirus copy number, we tried to amplify the whole genome using PCR. For seven of the samples, we obtained amplicons that corresponded to the whole genome. These were cloned and sequenced to 3× coverage to determine their consensus sequences. These 7 genomes varied from the index genome by 4 to 21 SNPs. The intron of the Rep gene contains a region with seven tandemly repeated hexamers, and deletions of one or more of the hexamers are observed in some of the genomes. Phylogenetic analysis of the complete genomes demonstrated that they formed a clade that included known Gemykibiviruses previously detected in human CSF, stool, and blood.

DISCUSSION

We used metagenomic NGS to detect Human gemykibivirus 2 Nepal/N0000051/2020 in CSF of an 8-year-old encephalitic child from Rupandehi district (Fig. 3) of Nepal, which is alongside the border of India. Further screening through qPCR identified an additional 12 positive specimens from patient samples collected in 2020 and 2022. We found that these cases were mostly concentrated in and around the south-central region of Nepal (Fig. 3).
The identified virus genomes were very closely related (97.96% nt. identity) to a gemykibivirus previously detected in CSF from three encephalitis patients from Sri Lanka (25). In addition, a distinct gemykibivirus (Human gemykibivirus 4) has also been reported in CSF of an encephalitis patient from China (15). Together with our study, these data implicate viruses in the genus Gemykibivirus as potential candidate agents of encephalitis. There is one report of Gemykibivirus in sewage from Nepal, which is also highly similar to the sequences we detected in Nepalese patients from 2020 and 2022. This suggests that gemykibivirus has been circulating in Nepal for at least the past decade. Furthermore, detection in sewage raises the possibility that gemykibivirus may be transmitted fecal-orally, similar to some neurotropic viruses such as polio and enteroviruses. Detection of highly similar viruses in patients in Tanzania (23) and Brazil (21) suggests that gemykibiviruses are globally widespread.
One limitation of this study is that the samples analyzed were residual specimens from a surveillance repository without additional available clinical metadata, thus limiting our knowledge of the precise symptoms, disease severity, and outcomes of these patients. It is also possible that there are additional microbes present in the index case that were not detected at the current sequencing depth. While detection of gemykibiviruses in presumptively sterile CSF supports the hypothesis that they could be causal agents of encephalitis, additional research to culture the virus and establish animal models to fulfill Koch’s postulates is needed to definitively establish causality. As the only gemykibivirus with a proven host to date infects a fungus (28, 30), one possibility is that gemykibivirus may infect another eukaryotic microbe present in these clinical samples, as has been reported for Redondoviruses that likely infect the protozoan Entamoeba gigivalis in the oral cavity (31). In addition, more prevalence studies in encephalitis and other diseases are also needed as are serological studies to define the extent of human infection by gemykibiviruses. Finally, additional, unbiased approaches are needed to define the etiologies of encephalitis in Nepal, and worldwide.

MATERIALS AND METHODS

Study population and collection of biospecimens

The study population focused on AES patients who were negative for JE IgM. Residual samples from national JE surveillance sentinel sites in Nepal were utilized. The index case CSF sample in the NPHL repository was collected in 2020 from Rupandehi district. For prevalence studies, 122 repository specimens (82 CSF, 40 sera) were collected in 2020 and 379 repository specimens (255 CSF, 124 sera) from 2022 were tested by PCR for gemykibivirus.

Total nucleic acid extraction

Total nucleic acid extraction was performed using the Invitrogen Pure Link Viral RNA/DNA mini kit (Thermo Fisher Scientific) and eluted in 50 µL volume following the instruction manual of the kit. Samples were stored at −80°C.

Metagenomic NGS analysis

Extracted total nucleic acid was randomly amplified as described previously (32) and used for library construction with NEBNext Ultra DNA Library Prep Kit for Illumina (New England Biolabs). The sample library was sequenced on the Illumina MiSeq instrument using the 2 × 250 bp paired-end protocol. NGS data were analyzed for the presence of viruses using CZID (33). NGS data is available at ENA: PRJEB72279.

Genome sequencing of index case and additional cases

The NGS contigs were confirmed using PCR, cloning, and sanger sequencing with primers (Table S1). Using a pair of primers that amplified the entire circular genome, Gemy1xgenomeF (5’TTAATCGATCTAGAGGATCCTTGTTAGATATCCATATGGCGG-3′) and Gemy1xgenomeR (5′-TTAGTAATGGGCCCGGATCCACGAGAGGAACACG-3′), three independent PCR reactions were performed, and the resulting fragments were cloned into pCR4.0 and sequenced using the Oxford Nanopore technologies (Plasmidsauraus). Additional positive cases were similarly amplified and whole genomes sequenced to 3× coverage.

Gemykibivirus qPCR development

Two sets of Taqman real-time PCR primers and probes were designed using express software (Applied Biosystems), one targeting the CP gene and the other targeting the REP gene. The primers and the probes were supplied by IDT (Integrated DNA Technologies, USA). The first assay, Gemy_1, targets the CP gene using primers GemykibiTM_8917F (5′-ACCTCTTATCCGGTTTGGCA-3′) and GemykibiTM_8917R (5′-AGCGCGAAATTCCTCTTGAC-3′) and the probe GemykibiTM_8917Probe(5’- [6-FAM]CGGACCTGA[ZEN]CCGGATGCCCGG[3IABkFQ]−3’) that uses FAM and the dual quencher Zen and Iowa Black. The second assay, Gemy_2, targets the REP gene with GemykibiTM_9967F (5′-GGTCAGAGCCTAGTGTTGTATG-3′) GemykibiTM_9967R (5′-CGACGTTGTCTGTGTCTTCT-3′) GemykibiTM_9967Probe (5’-[6-FAM]AAGACACTC[ZEN]TGGGCAAGAAGCC TT[IABkFQ]−3’) using the same fluor and quencher.
For both assays, standard curves were generated using serial 10-fold dilution ranging from 2 × 108 to 2 × 101 copies of positive control plasmid (plasmid PCR4 containing the respective target sequence). A 20-µL PCR mixture was made comprising 2 µL of extracted nucleic acid sample, 10 µL of 2× TaqMan Fast Advanced Master Mix (Thermo Fisher Scientific), and 5 pmol of each primer and probe. The PCR reactions were performed in 96-well plates on a CFX Opus 96 thermocycler (Bio-Rad) with one negative control nuclease free water in each row and one positive control of 2 × 103 copies per plate. The cycling conditions were 50°C for 2 mins, 95°C for 30 secs, and 40 cycles of 95°C for 5 secs followed by 60°C for 30 secs. The threshold of all plates was set at standard value, and data were analyzed using Bio-Rad CFX Maestro 2.3 software. Samples were counted as positive if their threshold cycle (Ct.) value was less than 33.

Phylogenetic analysis

Representative protein sequences of the REP gene of prototypes of each genus in the Genomoviridae were downloaded from GenBank. Alignments were generated using Clustal Omega (34). The alignment converted to fasta via http://sequenceconversion.bugaco.com/converter/biology/sequences/clustal_to_fasta.php. Maximum likelihood trees were generated with bootstrapping, using W-IQ-TREE (35). Trees were visualized using iTOL (36). All available complete genomes in the species Gemykibivirus humas2 were downloaded from Genbank along with representative genomes from the species Gemykibivirus humas 1, 3, 4, and 5, and the top 10 additional complete genomes with highest BLASTn scores. Alignments were generated using Clustal Omega (34) Maximum likelihood trees were generated with bootstrapping, using W-IQ-TREE (35). Trees were visualized using iTOL (36).

ACKNOWLEDGMENTS

This project was supported by National Institutes of Health grant U01AI151810.

SUPPLEMENTAL MATERIAL

Table S1 - msphere.00219-24-s0001.docx
Primers used for PCR.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

1.
Why encephalitis matters? report of the virtual meeting, 28-29 June 2022. 2023. Geneva World Health Organization. https://www.who.int/publications/i/item/9789240069176.
2.
Wang H, Zhao S, Wang S, Zheng Y, Wang S, Chen H, Pang J, Ma J, Yang X, Chen Y. 2022. Global magnitude of encephalitis burden and its evolving pattern over the past 30 years. J Infect 84:777–787.
3.
Department of health services annual report 2078/79. 2021. Kathmandu Government of Nepal Ministry of Health and Population. http://dohs.gov.np/wp-content/uploads/Annual%20Report%202078-79.pdf.
4.
Granerod J, Cunningham R, Zuckerman M, Mutton K, Davies NWS, Walsh AL, Ward KN, Hilton DA, Ambrose HE, Clewley JP, Morgan D, Lunn MP, Solomon T, Brown DWG, Crowcroft NS. 2010. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 138:783–800.
5.
Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, Schuster FL, Christie LJ, Tureen JH. 2006. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43:1565–1577.
6.
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS, UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. 2010. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844.
7.
Rayamajhi P, Nepal G, Ojha R, Rajbhandari R, Gajurel BP, Karn R. 2022. Evaluating cognitive outcomes in adult patients with acute encephalitis syndrome: a prospective study from a tertiary care center in Nepal. Encephalitis 2:36–44.
8.
Khanal B, Singh RR, Bhattacharya SK. 2012. Japanese encephalitis in eastern Nepal: access to the laboratory diagnosis. Int J Infect Dis 16:e88.
9.
Dhital B, Bhat N. 2022. Clinico-epidemiological presentation of acute encephalitis syndrome in patients visiting a tertiary hospital in Kathmandu, Nepal: a descriptive cross-sectional study. JGMC Nepal 15:168–172.
10.
Rayamajhi A, Ansari I, Ledger E, Bista KP, Impoinvil DE, Nightingale S, Kumar R, Mahaseth C, Solomon T, Griffiths MJ. 2011. Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study. BMC Infect Dis 11:294.
11.
Kumar Pant D, Tenzin T, Chand R, Kumar Sharma B, Raj Bist P. 2017. Spatio-temporal epidemiology of Japanese encephalitis in Nepal, 2007-2015. PLoS One 12:e0180591.
12.
Huppatz C, Durrheim DN, Levi C, Dalton C, Williams D, Clements MS, Kelly PM. 2009. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis 15:1359–1365.
13.
Mailles A, Stahl JP, Steering C, Investigators G. 2009. Infectious encephalitis in france in 2007: a national prospective study. Clin Infect Dis 49:1838–1847.
14.
Edridge AWD, Deijs M, Namazzi R, Cristella C, Jebbink MF, Maurer I, Kootstra NA, Buluma LR, van Woensel JBM, de Jong MD, Idro R, Boele van Hensbroek M, van der Hoek L. 2019. Novel orthobunyavirus identified in the cerebrospinal fluid of a Ugandan child with severe encephalopathy. Clin Infect Dis 68:139–142.
15.
Zhou C, Zhang S, Gong Q, Hao A. 2015. A novel gemycircularvirus in an unexplained case of child encephalitis. Virol J 12:197.
16.
Smits SL, Zijlstra EE, van Hellemond JJ, Schapendonk CME, Bodewes R, Schürch AC, Haagmans BL, Osterhaus ADME. 2013. Novel cyclovirus in human cerebrospinal fluid, Malawi, 2010-2011. Emerg Infect Dis 19:1511–1513.
17.
Liu Q, Wang X, Xie C, Ding S, Yang H, Guo S, Li J, Qin L, Ban F, Wang D, Wang C, Feng L, Ma H, Wu B, Zhang L, Dong C, Xing L, Zhang J, Chen H, Yan R, Wang X, Li W. 2021. A novel human acute encephalitis caused by pseudorabies virus variant strain. Clin Infect Dis 73:e3690–e3700.
18.
Manso CF, Bibby DF, Mohamed H, Brown DWG, Zuckerman M, Mbisa JL. 2020. Enhanced detection of DNA viruses in the cerebrospinal fluid of encephalitis patients using metagenomic next-generation sequencing. Front Microbiol 11:1879.
19.
Quan PL, Wagner TA, Briese T, Torgerson TR, Hornig M, Tashmukhamedova A, Firth C, Palacios G, Baisre-De-Leon A, Paddock CD, Hutchison SK, Egholm M, Zaki SR, Goldman JE, Ochs HD, Lipkin WI. 2010. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis 16:918–925.
20.
Varsani A, Krupovic M. 2021. Family genomoviridae: 2021 taxonomy update. Arch Virol 166:2911–2926.
21.
Zucherato VS, Giovanetti M, Costa LOA, Krause LMF, Alves DCC, Moreira RMA, Pimentel BMS, Haddad R, Bitencourt HT, Ciccozzi M, Alcantara LCJ, Kashima S, Covas DT, Slavov SN. 2023. Molecular identification of the emerging human gemykibivirus-2 (HuGkV-2) among Brazilian blood donors. Transfus Apher Sci 62:103516.
22.
International Committee on Taxonomy of Viruses (ICTV). 2023. Current ICTV taxonomy release. Available from: https://ictv.global/taxonomy
23.
Cordey S, Laubscher F, Hartley M-A, Junier T, Keitel K, Docquier M, Guex N, Iseli C, Vieille G, Le Mercier P, Gleizes A, Samaka J, Mlaganile T, Kagoro F, Masimba J, Said Z, Temba H, Elbanna GH, Tapparel C, Zanella M-C, Xenarios I, Fellay J, D’Acremont V, Kaiser L. 2021. Blood virosphere in febrile Tanzanian children. Emerg Microbes Infect 10:982–993.
24.
Wang J, Li Y, He X, Ma J, Hong W, Hu F, Zhao L, Li Q, Zhang J, Zhang C, Zhang F. 2019. Gemykibivirus genome in lower respiratory tract of elderly woman with unexplained acute respiratory distress syndrome. Clin Infect Dis 69:861–864.
25.
Phan TG, Mori D, Deng X, Rajindrajith S, Ranawaka U, Fan Ng TF, Bucardo-Rivera F, Orlandi P, Ahmed K, Delwart E. 2015. Small circular single stranded DNA viral genomes in unexplained cases of human encephalitis, diarrhea, and in untreated sewage. Virology 482:98–104.
26.
Orf GS, Olivo A, Harris B, Weiss SL, Achari A, Yu G, Federman S, Mbanya D, James L, Mampunza S, Chiu CY, Rodgers MA, Cloherty GA, Berg MG. 2023. Metagenomic detection of divergent insect- and bat-associated viruses in plasma from two African individuals enrolled in blood-borne surveillance. Viruses 15:1022.
27.
Siqueira JD, Curty G, Xutao D, Hofer CB, Machado ES, Seuánez HN, Soares MA, Delwart E, Soares EA. 2019. Composite analysis of the virome and bacteriome of HIV/HPV co-infected women reveals proxies for immunodeficiency. Viruses 11:422.
28.
Yu X, Li B, Fu Y, Jiang D, Ghabrial SA, Li G, Peng Y, Xie J, Cheng J, Huang J, Yi X. 2010. A geminivirus-related DNA mycovirus that confers hypovirulence to a plant pathogenic fungus. Proc Natl Acad Sci U S A 107:8387–8392.
29.
Heyraud F, Matzeit V, Schaefer S, Schell J, Gronenborn B. 1993. The conserved nonanucleotide motif of the geminivirus stem-loop sequence promotes replicational release of virus molecules from redundant copies. Biochimie 75:605–615.
30.
Kinsella CM, Deijs M, Becker C, Broekhuizen P, van Gool T, Bart A, Schaefer AS, van der Hoek L. 2022. Host prediction for disease-associated gastrointestinal cressdnaviruses. Virus Evol 8:veac087.
31.
Keeler EL, Merenstein C, Reddy S, Taylor LJ, Cobián-Güemes AG, Zankharia U, Collman RG, Bushman FD. 2023. Widespread, human-associated redondoviruses infect the commensal protozoan Entamoeba gingivalis. Cell Host Microbe 31:58–68.
32.
Lim ES, Zhou Y, Zhao G, Bauer IK, Droit L, Ndao IM, Warner BB, Tarr PI, Wang D, Holtz LR. 2015. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med 21:1228–1234.
33.
Kalantar KL, Carvalho T, de Bourcy CFA, Dimitrov B, Dingle G, Egger R, Han J, Holmes OB, Juan Y-F, King R, et al. 2020. IDseq-An open source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring. Gigascience 9:giaa111.
34.
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539.
35.
Trifinopoulos J, Nguyen L-T, von Haeseler A, Minh BQ. 2016. W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis. Nucleic Acids Res 44:W232–W235.
36.
Letunic I, Bork P. 2021. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49:W293–W296.

Information & Contributors

Information

Published In

cover image mSphere
mSphere
Volume 9Number 730 July 2024
eLocator: e00219-24
Editor: Benhur Lee, Icahn School of Medicine at Mount Sinai, New York, New York, USA
PubMed: 38904383

History

Received: 15 March 2024
Accepted: 8 May 2024
Published online: 21 June 2024

Keywords

  1. acute encephalitis syndrome
  2. gemykibivirus
  3. metagenomic analysis
  4. emerging infection

Data Availability

Complete genome sequences are available at GenBank (Accession# PP270194-PP270201).

Contributors

Authors

Tribhuvan University Central Department of Biotechnology, Kathmandu, Nepal
Author Contributions: Investigation, Writing – original draft, and Writing – review and editing.
Smita Shrestha
Tribhuvan University Central Department of Biotechnology, Kathmandu, Nepal
Author Contributions: Investigation and Writing – original draft.
Susan Vernon
Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA
Author Contributions: Data curation, Formal analysis, Investigation, and Methodology.
Lindsay Droit
Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA
Author Contributions: Data curation, Formal analysis, Investigation, and Methodology.
Kathie A. Mihindukulasuriya
Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA
Author Contributions: Data curation, Formal analysis, Investigation, and Methodology.
Mamta Tamang
Tribhuvan University Central Department of Biotechnology, Kathmandu, Nepal
Author Contribution: Investigation.
Lata Karki
Tribhuvan University Central Department of Biotechnology, Kathmandu, Nepal
Author Contribution: Investigation.
Annie Elong Ngono
La Jolla Institute for Immunology, San Diego, California, USA
Author Contributions: Resources and Writing – review and editing.
Bimlesh Jha
National Public Health Laboratory, Kathmandu, Nepal
Author Contribution: Investigation.
Bal Krishna Awal
National Public Health Laboratory, Kathmandu, Nepal
Author Contributions: Resources and Validation.
Bimal Sharma Chalise
Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal
Author Contributions: Supervision and Writing – review and editing.
Runa Jha
National Public Health Laboratory, Kathmandu, Nepal
Author Contributions: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Validation, and Writing – review and editing.
La Jolla Institute for Immunology, San Diego, California, USA
Author Contributions: Resources and Writing – review and editing.
Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA
Author Contributions: Conceptualization, Project administration, Resources, Supervision, Validation, Writing – original draft, and Writing – review and editing.
Tribhuvan University Central Department of Biotechnology, Kathmandu, Nepal
Author Contributions: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, and Writing – review and editing.

Editor

Benhur Lee
Editor
Icahn School of Medicine at Mount Sinai, New York, New York, USA

Notes

Eans Tara Tuladhar and Smita Shrestha contributed equally to this article. Author order was determined alphabetically.
Runa Jha, Sujan Shresta, David Wang, and Krishna Das Manandhar are joint senior authors.
The authors declare no conflict of interest.

Ethics Approval

This study was approved by the Nepal Health Research Council (approval# 274-2020) and the Human Research Protection Office of Washington University in Saint Louis (202004087).

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures

Tables

Media

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy